Takeda, Sweden-based Karolinska Institutet and The Structural Genomics Consortium entered into a precompetitive and proprietary collaboration agreement to research and test potential intervention points for inflammatory bowel disease.
Takeda Pharmaceuticals U.S.A. donated $100,000 to local and regional nonprofits as part of its annual Takeda Cares Day.
EnteroMedics acquired ReShape Medical and its ReShape Dual Weight Loss Balloon, a minimally invasive intragastric balloon system.
TransMed7, a medical device company, appointed Michael Demeure, MD, chair of its endocrine and gastrointestinal health team.
More articles on gastroenterology:
Allergan under scrutiny for Restasis patent transfer — 4 insights
GI leader to know: Dr. Gary Varilek of Gastroenterology Specialties
Stock market week-in-review for 5 large GI companies — Oct. 2-6
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
